Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-01 Sale | 2024-04-01 6:46 pm | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 24,662 | $77.24 | $1,904,942 | 0 (Direct) | View |
| 2024-03-14 Sale | 2024-03-15 8:05 pm | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 32,323 | $69.84 | $2,257,449 | 167,668 (Indirect Direct) | View |
| 2023-09-15 Sale | 2023-09-15 6:30 pm | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 29,588 | $75.18 | $2,224,430 | 428,953 (Indirect Direct) | View |
| 2021-11-19 Purchase | 2021-11-23 07:30 am | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 3,950 | $37.3 | $147,350 | 167,668 (Indirect Direct) | View |
| 2021-11-18 Purchase | 2021-11-22 07:31 am | Axsome Therapeutics Inc. | AXSM | Pizzie Nick CHIEF FINANCIAL OFFICER | 955 | $35.26 | $33,676 | 41,931 (Indirect Direct) | View |
| 2021-11-18 Purchase | 2021-11-22 07:30 am | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 1,430 | $35.09 | $50,181 | 426,528 (Indirect Direct) | View |
| 2021-11-17 Purchase | 2021-11-19 07:30 am | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 3,300 | $34.52 | $113,922 | 10,102 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-01 Exercise | 2024-04-01 6:46 pm | 2014-10-03 2024-04-03 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 24,662 | $0 | 0 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-01 6:46 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 24,662 | $1.3 | 0 (Direct) | View |
| 2024-03-14 Exercise | 2024-03-15 8:05 pm | 2020-06-07 2029-06-07 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 32,323 | $0 | 167,668 (Direct) | View |
| 2024-03-14 Exercise | 2024-03-15 8:05 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 13,000 | $22.03 | 167,668 (Direct) | View |
| 2024-03-14 Exercise | 2024-03-15 8:05 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 16,976 | $25.53 | 167,668 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-15 8:05 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 2,347 | $29.91 | 167,668 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 6:34 pm | 2024-02-27 2034-02-26 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 1,425 | $0 | 1,425 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 6:34 pm | 2024-02-27 2034-02-26 | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 1,519 | $0 | 1,519 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 6:34 pm | N/A 2034-02-26 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. CHIEF OPERATING OFFICER | 50,852 | $0 | 50,852 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 6:25 pm | N/A 2034-02-26 | Axsome Therapeutics Inc. | AXSM | Pizzie Nick CHIEF FINANCIAL OFFICER | 44,496 | $0 | 44,496 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 6:20 pm | N/A 2034-02-26 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER 10% Owner | 135,078 | $0 | 135,078 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 6:18 pm | 2024-02-27 2034-02-26 | Axsome Therapeutics Inc. | AXSM | Mahony Susan Director | 191 | $0 | 191 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 5:39 pm | N/A 2034-02-26 | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 36,549 | $0 | 36,549 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-12 8:33 pm | 2024-10-10 2033-10-10 | Axsome Therapeutics Inc. | AXSM | Mahony Susan Director | 7,375 | $0 | 7,375 (Direct) | View |
| 2023-09-15 Exercise | 2023-09-15 6:30 pm | 2015-09-16 2024-09-16 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 11,016 | $0 | 428,953 (Direct) | View |
| 2023-09-15 Exercise | 2023-09-15 6:30 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 11,016 | $3.67 | 428,953 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 6:22 pm | 2024-06-02 2033-06-02 | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 5,681 | $0 | 5,681 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 6:22 pm | 2024-06-02 2033-06-02 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 5,681 | $0 | 5,681 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 6:21 pm | 2024-06-02 2033-06-02 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 5,681 | $0 | 5,681 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:16 pm | N/A 2033-03-01 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER 10% Owner | 172,432 | $0 | 172,432 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:15 pm | N/A 2033-03-01 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. CHIEF OPERATING OFFICER | 64,915 | $0 | 64,915 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:14 pm | N/A 2033-03-01 | Axsome Therapeutics Inc. | AXSM | Pizzie Nick CHIEF FINANCIAL OFFICER | 56,800 | $0 | 56,800 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:14 pm | N/A 2033-03-01 | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 46,656 | $0 | 46,656 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:13 pm | 2023-03-02 2033-03-01 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 2,870 | $0 | 2,870 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:13 pm | 2023-03-02 2033-03-01 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 2,082 | $0 | 2,082 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:12 pm | 2023-03-02 2033-03-01 | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 2,224 | $0 | 2,224 (Direct) | View |
| 2023-01-03 Exercise | 2023-01-04 4:11 pm | 2013-03-22 2023-03-21 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 17,501 | $0 | 447,525 (Direct) | View |
| 2023-01-03 Exercise | 2023-01-04 4:11 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 17,501 | $1.3 | 447,525 (Direct) | View |
Ownership | 2022-06-15 4:31 pm | N/A 2031-12-13 | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 0 | $0 | 142,335 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 4:08 pm | 2023-06-03 2032-06-03 | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 16,976 | $0 | 16,976 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 4:07 pm | 2023-06-03 2032-06-03 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 16,976 | $0 | 16,976 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 4:07 pm | 2023-06-03 2032-06-03 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 16,976 | $0 | 16,976 (Direct) | View |
| 2022-03-15 Exercise | 2022-03-17 07:05 am | 2013-03-22 2023-03-21 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 3,496 | $0 | 447,525 (Direct) | View |
| 2022-03-15 Exercise | 2022-03-17 07:05 am | N/A N/A | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 3,496 | $1.3 | 447,525 (Direct) | View |
| 2022-03-04 Option Award | 2022-03-08 5:04 pm | N/A 2032-03-03 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER 10% Owner | 320,516 | $0 | 320,516 (Direct) | View |
| 2022-03-04 Option Award | 2022-03-08 5:03 pm | N/A 2032-03-03 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. CHIEF OPERATING OFFICER | 137,395 | $0 | 137,395 (Direct) | View |
| 2022-03-04 Option Award | 2022-03-08 5:02 pm | N/A 2032-03-03 | Axsome Therapeutics Inc. | AXSM | Pizzie Nick CHIEF FINANCIAL OFFICER | 119,048 | $0 | 119,048 (Direct) | View |
| 2022-03-04 Option Award | 2022-03-08 5:00 pm | 2022-03-04 2032-03-03 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 2,798 | $0 | 2,798 (Direct) | View |
| 2022-03-04 Option Award | 2022-03-08 5:00 pm | 2022-03-04 2032-03-03 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 2,347 | $0 | 2,347 (Direct) | View |
| 2022-03-04 Option Award | 2022-03-08 5:00 pm | 2022-03-04 2032-03-03 | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 2,337 | $0 | 2,337 (Direct) | View |
| 2021-11-12 Option Award | 2021-11-15 7:55 pm | N/A 2031-11-11 | Axsome Therapeutics Inc. | AXSM | Pizzie Nick CHIEF FINANCIAL OFFICER | 36,086 | $0 | 36,086 (Direct) | View |
| 2021-11-12 Option Award | 2021-11-15 7:54 pm | N/A 2031-11-11 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. CHIEF OPERATING OFFICER | 41,638 | $0 | 41,638 (Direct) | View |